- Home
- KC vs HAE Comparison
KC vs HAE Comparison
Compare KC & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KC
- HAE
- Stock Information
- Founded
- KC 2012
- HAE 1971
- Country
- KC China
- HAE United States
- Employees
- KC N/A
- HAE N/A
- Industry
- KC Computer Software: Prepackaged Software
- HAE Medical/Dental Instruments
- Sector
- KC Technology
- HAE Health Care
- Exchange
- KC Nasdaq
- HAE Nasdaq
- Market Cap
- KC 3.2B
- HAE 3.3B
- IPO Year
- KC 2020
- HAE 1991
- Fundamental
- Price
- KC $13.82
- HAE $54.44
- Analyst Decision
- KC Strong Buy
- HAE Buy
- Analyst Count
- KC 3
- HAE 11
- Target Price
- KC $11.07
- HAE $86.73
- AVG Volume (30 Days)
- KC 1.7M
- HAE 1.1M
- Earning Date
- KC 08-20-2025
- HAE 08-07-2025
- Dividend Yield
- KC N/A
- HAE N/A
- EPS Growth
- KC N/A
- HAE 46.89
- EPS
- KC N/A
- HAE 3.28
- Revenue
- KC $1,177,715,737.00
- HAE $1,346,046,000.00
- Revenue This Year
- KC $23.79
- HAE N/A
- Revenue Next Year
- KC $16.38
- HAE $6.50
- P/E Ratio
- KC N/A
- HAE $16.63
- Revenue Growth
- KC 20.27
- HAE 0.91
- 52 Week Low
- KC $2.02
- HAE $50.68
- 52 Week High
- KC $22.26
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- KC 48.48
- HAE 35.66
- Support Level
- KC $13.18
- HAE $52.58
- Resistance Level
- KC $15.18
- HAE $56.64
- Average True Range (ATR)
- KC 0.63
- HAE 1.34
- MACD
- KC -0.07
- HAE 0.61
- Stochastic Oscillator
- KC 45.16
- HAE 45.81
About KC Kingsoft Cloud Holdings Limited
Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.